$1.07
3.60% day before yesterday
Nasdaq, Dec 27, 10:01 pm CET
ISIN
US37148K1007
Symbol
GBIO
Sector
Industry

Generation Bio Co Stock price

$1.07
-0.36 25.17% 1M
-1.78 62.46% 6M
-0.58 35.15% YTD
-0.76 41.53% 1Y
-6.77 86.35% 3Y
-23.62 95.67% 5Y
-23.62 95.67% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.04 3.60%
ISIN
US37148K1007
Symbol
GBIO
Sector
Industry

Key metrics

Market capitalization $71.47m
Enterprise Value $-19.52m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.19
EV/Sales (TTM) EV/Sales -1.05
P/S ratio (TTM) P/S ratio 3.85
P/B ratio (TTM) P/B ratio 0.68
Revenue growth (TTM) Revenue growth 514.08%
Revenue (TTM) Revenue $18.58m
EBIT (operating result TTM) EBIT $-90.22m
Free Cash Flow (TTM) Free Cash Flow $-104.36m
Cash position $184.77m
EPS (TTM) EPS $-2.19
P/E forward negative
P/S forward 3.94
EV/Sales forward negative
Short interest 3.82%
Show more

Is Generation Bio Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Generation Bio Co Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Generation Bio Co forecast:

4x Buy
57%
3x Hold
43%

Analyst Opinions

7 Analysts have issued a Generation Bio Co forecast:

Buy
57%
Hold
43%

Financial data from Generation Bio Co

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
19 19
513% 513%
100%
- Direct Costs 5.08 5.08
4% 4%
27%
14 14
697% 697%
73%
- Selling and Administrative Expenses 35 35
22% 22%
189%
- Research and Development Expense 64 64
23% 23%
342%
-85 -85
34% 34%
-458%
- Depreciation and Amortization 5.08 5.08
4% 4%
27%
EBIT (Operating Income) EBIT -90 -90
33% 33%
-486%
Net Profit -145 -145
17% 17%
-783%

In millions USD.

Don't miss a Thing! We will send you all news about Generation Bio Co directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Generation Bio Co Stock News

Neutral
GlobeNewsWire
2 months ago
CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today presented data on its cell-targeted lipid nanoparticle (ctLNP) and immune-quiet DNA (iqDNA) platforms at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual Congress.
Neutral
GlobeNewsWire
4 months ago
CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 10:20 a.m....
Neutral
GlobeNewsWire
5 months ago
CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co.  (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the Canaccord Genuity 44th Annual Growth Conference on Tuesday, August 13th, 2024 at 2:30 ...

Company Profile

Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of eight programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, Massachusetts.

Head office United States
CEO Cameron McDonough
Employees 174
Founded 2016
Website www.generationbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today